Mountford P J, Allsopp M J, Baird A C, North C I, Hall F M, Wells C P, Coakley A J
Department of Nuclear Medicine, Kent & Canterbury Hospital, UK.
Nucl Med Commun. 1985 Feb;6(2):109-14.
The range of leucocyte labelling efficiencies with 111In-oxine for a group of patients extended significantly (P = 0.05) below that obtained for a series of labellings of the same normal blood from a volunteer. A retrospective analysis was made of the results in the two groups to identify the cause of this difference in range. The labelling efficiency for patients did not vary with the volume of 111In-oxine, and was independent of the whole blood leucocyte concentration. The difference between the average labelling efficiencies obtained for a group of patients and the normal series labelled by the same operator was more significant than the difference in average labelling efficiencies obtained by different operators. It was concluded that biological variation in patients' blood, rather than operator technique, must have been a more important cause to the difference in the labelling efficiency range between patients and normal. It was also concluded that variations of contaminant platelet-bound activity and of plasma viscosity were greater in the patient group than the normal series, and contributed to this difference in labelling efficiency range.
一组患者使用铟 - 111 奥克辛(111In - oxine)标记白细胞的效率范围显著低于(P = 0.05)从一名志愿者的同一正常血液进行一系列标记所获得的效率范围。对两组结果进行回顾性分析以确定该范围差异的原因。患者的标记效率不随铟 - 111 奥克辛的体积变化,且与全血白细胞浓度无关。同一操作人员对一组患者和正常样本系列进行标记所获得的平均标记效率之间的差异,比不同操作人员获得的平均标记效率差异更显著。得出的结论是,患者血液中的生物学变异而非操作人员的技术,必定是导致患者与正常样本标记效率范围差异的更重要原因。还得出结论,患者组中污染物血小板结合活性和血浆粘度的变化比正常样本系列更大,这也导致了标记效率范围的这种差异。